<DOC>
	<DOCNO>NCT00690521</DOCNO>
	<brief_summary>The purpose research study compare effectiveness hydrochlorothiazide metolazone combination furosemide . Patients heart failure suffer swell much fluid body . Furosemide , hydrochlorothiazide , metolazone water pill use treat swell . For patient , take furosemide alone successful . However , sometimes patient need add another water pill . Doctors usually add either metolazone hydrochlorothiazide . It clear water pill well add furosemide . The purpose study determine water pill add furosemide best reduce excess fluid body .</brief_summary>
	<brief_title>A Comparison Hydrochlorothiazide Metolazone Combination With Furosemide Congestive Heart Failure Patients</brief_title>
	<detailed_description>Objective : To establish combination diuretic effective promote diuresis congestive heart failure patient . Secondary Objectives : To determine duration action furosemide monotherapy combination either hydrochlorothiazide metolazone . To determine effect diuretic combination therapy neurohormonal activation . Background : Diuretic resistance occur potent diuretic drug , furosemide , give therapeutic dos fail reduce extracellular fluid volume desire level edematous patient . Studies show metolazone hydrochlorothiazide demonstrate synergistic response use combination furosemide congestive heart failure patient . The current guideline treat diuretic resistance congestive heart failure patient recommend metolazone-furosemide combination . However , evidence conclude combination superior hydrochlorothiazide-furosemide increase diuresis . Methods : Randomized , double-blind , crossover study compare efficacy hydrochlorothiazide metolazone combination stable dos furosemide 13 patient congestive heart failure . The primary endpoint change urinary output . Secondary endpoint change weight , neurohormone ( angiotensin II , catecholamine , brain natriuretic peptide , aldosterone ) , electrocardiographic parameter ventricular instability . Study procedure perform UNM General Clinical Research Center . Patients hospitalize 2 separate 4-day admission , separate 1-week washout period . At admission patient receive furosemide combination either metolazone hydrochlorothiazide ( metolazone one admission hydrochlorothiazide ) . Following administration combination therapy , blood urine sample collect throughout day chart onset magnitude effect treatment regimen . Various hemodynamic , renal , endocrine , neurohormonal parameter assesed effect combination treatment ventricular instability use 12-lead electrocardiography . Data analyze use ANOVA compare change baseline Student t-test analyze intertreatment difference . All statistical analysis perform use SAS v6.12 .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Metolazone</mesh_term>
	<criteria>Age &gt; 18 year Diagnosis chronic congestive heart failure ejection fraction â‰¤45 % Currently stable regimen furosemide consist daily dose least 80 mg least two week . Patients receive ACEinhibitors and/or betablockers must take medication least two week stable dos . Renal dysfunction ( serum creatinine &gt; 2 mg/dl creatinine clearance &lt; 30 ml/min calculate Cockroft Gault equation ) Hepatic dysfunction ( AST ALT &gt; 3 time upper limit normal ) Hypokalemia ( &lt; 4.0 mg/dl ) Concomitant treatment diuretic furosemide ( exception spironolactone ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>congestive heart failure</keyword>
	<keyword>diuretic</keyword>
	<keyword>combination</keyword>
</DOC>